AG0030JY

3056-17-5 | Thymidine, 2',3'-didehydro-3'-deoxy-

Chemical structure of Thymidine, 2',3'-didehydro-3'-deoxy-, CAS 3056-17-5
AG0030JY
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 3056-17-5
Catalog Number AG0030JY(AGN-PC-0O8RH9)
Chemical Name Thymidine, 2',3'-didehydro-3'-deoxy-
IUPAC Name 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione
InChI InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1
InChI Key XNKLLVCARDGLGL-JGVFFNPUSA-N
MDL Number MFCD00132921
Molecular Formula C10H12N2O4
Molecular Weight 224.2133
NSC Number 759897
SMILES OC[C@@H]1C=C[C@@H](O1)N1C(NC(C(=C1)C)=O)=O
UNII BO9LE4QFZF
Synonyms
2',3' Didehydro 3' deoxythymidine, 2',3'-Didehydro-2',3'-dideoxythmidine, 2',3'-Didehydro-3'-deoxythymidine, BMY 27857, BMY-27857, BMY27857, D4T, Stavudine, Stavudine, Monosodium Salt, Zerit, stavudine, 3056-17-5, sanilvudine, Zerit, 2',3'-Didehydro-3'-deoxythymidine, Estavudina, Stavudinum, Zerit Xr, Zerut XR, BMY-27857, Stavudinum [INN-Latin], 2',3'-Anhydrothymidine, Estavudina [INN-Spanish], d4T, Thymidine, 2',3'-didehydro-3'-deoxy-, ddeThd, D 4T (nucleoside), BMY 27857, 3'-Deoxy-2'-thymidinene, 2',3'-Didehydro-3'-deoxythimidine, Stavudine [USAN:BAN:INN], D 4T, Dideoxydidehydrothymidine, UNII-BO9LE4QFZF, 3'-Deoxy-2',3'-didehydrothymidine, 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine, NSC 163661, HSDB 7338, BO9LE4QFZF, CHEMBL991, BRN 0618327, 2'-Thymidinene, 3'-deoxy-, 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione, MLS000028546, STV, CHEBI:63581, XNKLLVCARDGLGL-JGVFFNPUSA-N, Stavudine (d4T), 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione, 1-[(2R,5S)-5-(HYDROXYMETHYL)-2,5-DIHYDROFURAN-2-YL]-5-METHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE, NCGC00023212-07, SMR000058350, DSSTox_CID_3819, 1-((2R,5S)-5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione, DSSTox_RID_77198, DSSTox_GSID_23819, ddeTyd, Zent, Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)- (7CI,8CI), Stavudine [USAN:INN:BAN], CAS-3056-17-5, Zerit(TM), Sanilvudine (JAN), 3'-Deoxy-2',3'-didehydrothymidine, 98%, Zerit (TN), SR-01000075802, Stavudine (USAN/INN), D4T & GM-CSF, Stavudin, NSC163661, Stavudine [USAN:USP:INN:BAN], D4TMBY-27857-3, PubChem5805, AC1Q6BSH, Opera_ID_1281, 3'-deoxythymidin-2'-ene, D 1413, AC1L2BQ9, cid_5155, 3''-deoxy-2''-thymidine, Lopac0_000336, SCHEMBL38661, 2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (DDI), cid_18283, MLS000759504, MLS001055348, MLS001077292, MLS001424091, MLS006011922, BIDD:GT0082, 2',3'-Anhydrothymidine; d4T, DTXSID1023819, CTK8B1419, 1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine, HMS2051O20, HMS2234C10, HMS3039O05, HMS3259L21, HMS3261C13, HMS3428C07, HMS3714N22, Pharmakon1600-01502339, ZINC137884, BCP02952, HY-B0116, Tox21_110886, Tox21_201393, Tox21_300583, Tox21_500336, ABP000995, ANW-26914, BBL033763, BDBM50013111, MFCD00132921, NSC759897, STK801888, 2',3'-Didehydro-3'-deoxy-thymidine, AKOS005622554, Tox21_110886_1, AC-5263, AN-7246, CCG-100902, CS-1872, DB00649, KS-1115, LP00336, LS-1160, MCULE-9252477726, NC00152, NC00684, NSC-759897, RP07238, KS-00000H34, 2'',3''-didehydro-3''-deoxythymidine, 3''-deoxy-2'',3''-didehydrothymidine, 3'-Deoxy-2',3'-didehydro-D-thymidine, NCGC00023212-03, NCGC00023212-04, NCGC00023212-05, NCGC00023212-08, NCGC00023212-09, NCGC00023212-10, NCGC00023212-11, NCGC00023212-12, NCGC00023212-13, NCGC00023212-14, NCGC00254372-01, NCGC00258944-01, NCGC00261021-01, 1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2, AJ-12338, BC203877, BR-77340, CPD000058350, CPD000673569, H940, SAM001246729, SAM002589948, SC-03292, SMR000673569, ZB004848, 2',3'-didehydro-2',3'-dideoxythymidine, AB0013374, AB1009564, Thymidine, 2',3'-didehydro-, 3'-deoxy-, D3580, EU-0100336, FT-0082665, FT-0603625, 2'',3''-dideoxy-2'',3''-didehydrothymidine, C07312, D00445, J10003, S-2155, AB00383018_18, 056S175, A820433, J-700246, Q-201742, SR-01000075802-1, SR-01000075802-4, 2',3'-Didehydro-3'-deoxythymidine, >=98% (TLC), Z1695906749, Stavudine, European Pharmacopoeia (EP) Reference Standard, 1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine, Stavudine, United States Pharmacopeia (USP) Reference Standard, 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (ddeThd), 1-[(2R,5S)-2,5-Dihydro-5-(hydroxymethyl)-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione, 3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor, Stavudine for system suitability, European Pharmacopoeia (EP) Reference Standard, 1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-(1H,3H)-dione, null, staduvine, Stavudine, Monosodium Salt, D0Z8EX, BMY27857, Bristol-Myers Brand of Stavudine, 2',3' Didehydro 3' deoxythymidine, C10H12N2O4, C10H14N2O4, CID18283, DRG-0043, 2',3'-Didehydro-2',3'-dideoxythmidine, C10-H12-N2-O4, CS-O-10815, Bristol-Myers Squibb Brand of Stavudine, D018119, 1-(2,3-dideoxy-beta-glycero-pent-2-enofuranosyl)thymine, Thymine, 1-(2,3-dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)-, Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-(7CI,8CI), 1-((2R,5S)-2,5-dihydro-5-(hydroxymethyl)furan-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 3'-Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor, 2',3'-Didehydro-3'-deoxythmidine, 98%, a nucleoside analog that inhibits reverse transcriptase - 1G 1g, DHT, DTH,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited